BioMarin building
Pharma

Trial results set up BioMarin for expansion of Voxzogo

With phase 3 results that have “exceeded” its expectations, BioMarin looks set up to gain a label expansion for dwarfism drug Voxzogo.
Kevin Dunleavy May 21, 2026 10:23am
Close up image of wooden cubes with alphabet Q1 on office desk - stock photo

Led by Lilly, 8 companies reach double-digit revenue gains in Q1

May 21, 2026 9:00am
The Case for Direct-to-Patient Is Clear The Challenge Now is Successful Execution

DTP is Decided: Now Comes the Hard Part

Brought to you by Gifthealth
18th birthday cupcake teenager young adult

Ipsen details growing pains as teens transition to adult care

May 20, 2026 11:51am
SQ81054png

Doceree launches Daily Command, an AI platform for brand teams co-built by pharma leaders

Brought to you by Doceree
Food and Drug Administration

Regulatory tracker: FDA sets date for possible Anktiva expansion

May 20, 2026 11:20am
More News

BMS taps Anthropic’s Claude for enterprise-wide AI adoption

May 20, 2026 10:16am

Amgen lures new CFO back from Galderma with hefty bonus

May 20, 2026 10:03am

Gilead, Yuhan expand partenership with $140M API contract

May 20, 2026 9:57am

BeOne kicks off ‘One Save’ campaign with Tim Howard

May 20, 2026 6:00am